首页 | 本学科首页   官方微博 | 高级检索  
     


High-throughput mass spectrometry screening for inhibitors of phosphatidylserine decarboxylase
Authors:Forbes Chris D  Toth Joshuaine G  Ozbal Can C  Lamarr William A  Pendleton Jennifer A  Rocks Sandra  Gedrich Richard W  Osterman David G  Landro James A  Lumb Kevin J
Affiliation:Department of Research Technologies, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA.
Abstract:A high-throughput mass spectrometry assay to measure the catalytic activity of phosphatidylserine decarboxylase (PISD) is described. PISD converts phosphatidylserine to phosphatidylethanolamine during lipid synthesis. Traditional methods of measuring PISD activity are low throughput and unsuitable for the high-throughput screening of large compound libraries. The high-throughput mass spectrometry assay directly measures phosphatidylserine and phosphatidylethanolamine using the RapidFiretrade mark platform at a rate of 1 sample every 7.5 s. The assay is robust, with an average Z' value of 0.79 from a screen of 9920 compounds. Of 60 compounds selected for confirmation, 54 are active in dose-response studies. The application of high-throughput mass spectrometry permitted a high-quality screen to be performed for an otherwise intractable target.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号